Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole RNA sequencing to identify targets of ETS-4 and REGE-1

ABSTRACT: Whole RNA sequencing to identify targets of ETS-4 and REGE-1

PROVIDER: PRJNA302658 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2924280.fastq.gz	Fastqsanger.gz
	SRR2924300.fastq.gz	Fastqsanger.gz
	SRR2924281.fastq.gz	Fastqsanger.gz
	SRR2924301.fastq.gz	Fastqsanger.gz
	SRR2924302.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Whole RNA sequencing to identify targets of ets-4 that are responsible for rege-1 (C30F12.1) phenotype

Project description:Ets-4 was previously identified as a suppressor of rege-1(rrr13) phenotype. The goal of this experiment was to identify down-stream regulators of ETS-4, which facilitate this suppression.

2016-10-18 | GSE75160 | GEO

Whole RNA sequencing to identify targets of the RNase domain protein encoded by rege-1 (C30F12.1)

Project description:The goal was to identify targets of the RNase REGE-1 by whole RNA sequencing.

2016-10-18 | GSE75162 | GEO

RNA-Sequencing to identify the transcriptional targets of Rai1

Project description:RNA-Sequencing to identify the transcriptional targets of Rai1

| PRJNA630685 | ENA

Whole RNA sequencing to identify targets of ETS-4 and REGE-1

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-10-18 | GSE75163 | GEO

Whole genome RNA-Sequencing analysis to identify targets of miR-642a-5p in 22Rv1 prostate cancer cells.

Project description:Whole genome RNA-Sequencing analysis to identify targets of miR-642a-5p in 22Rv1 prostate cancer cells.

| PRJNA674323 | ENA

Chromatin immunoprecipitation of human Hela cells grown under serum starved condtions to identify new targets genes for ETS-domain transcription factor Elk-1

Project description:Chromatin immunoprecipitation coupled with microarray analysis (ChIP-chip) was carried out to identify new target genes for ETS-domain transcription factor Elk-1. Experiment was done in Hela cells under serum starved conditions.

2009-08-11 | E-MEXP-1527 | biostudies-arrayexpress

Discovery of Non-ETS Gene Fusions using RNA Sequencing

Project description:Half of prostate cancers harbor gene fusions between TMPRSS2 and members of the ETS transcription factor family. To date little is known about the presence of non-ETS fusion events in prostate cancer. We employed next-generation transcriptome sequencing (RNA-Seq) in order to explore the whole transcriptome of 25 human prostate cancer samples for the presence of chimeric fusion transcripts. We generated more than 1 billion sequence reads and used a novel computational approach (FusionSeq) in order to identify novel gene fusion candidates with high confidence. In total, we discovered and characterized seven new cancer-specific gene fusions, two involving the ETS genes ETV1 and ERG, and five involving non-ETS genes such as CDKN1A (p21), CD9 and IKBKB (IKK-beta), genes known to exhibit key biological roles in cellular homeostasis or assumed to be critical in tumorigenesis of other tumor entities, as well as the oncogene PIGU and the tumor suppressor gene RSRC2. The novel gene fusions are found to be of low frequency but interestingly, the non-ETS fusions were all present in prostate cancer harboring the TMPRSS2-ERG gene fusion. Future work will focus on determining if the ETS rearrangements in prostate cancer are associated or directly predispose to a rearrangement prone phenotype.

| phs000310 | dbGaP

RNA sequencing analysis to identify gene targets of Kaposi's sarcoma herpesvirus (KSHV) ORF24

Project description:RNA sequencing analysis to identify gene targets of Kaposi's sarcoma herpesvirus (KSHV) ORF24

| PRJNA522743 | ENA

Analysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers

Project description:Deregulated expression of ETS transcription factors with oncogenic and tumor suppressor function occurs frequently in prostate cancer leading to profound alterations of the cancer transcriptome. By integrating genomic and functional studies we identified key targets of the aberrantly expressed ETS factors, ERG and ESE3. Altered expression of ETS factors led to the induction of the polycomb group protein EZH2 and silencing of the tumor suppressor Nkx3.1. Nkx3.1 was controlled by ERG and ESE3 both directly via binding to ETS binding sites in the gene promoter and indirectly via EZH2-induced histone H3K27 methylation. This may represent a general mechanism linking aberrantly expressed ETS with deregulation of epigenetic pathways and global reprogramming of the prostate epithelial cell transcriptome in prostate tumorigenesis. Keywords: prostate cancer, gene expression profiling, ETS genes In this study we show that deregulated expression of ETS factors with opposite functions is highly frequent in prostate cancer. Our study uncovers a previously unrecognized link between aberrant expression of ETS factors, deregulation of epigenetic pathways and silencing of tumor suppressor genes in prostate cancer and shows that partially distinct transcriptional programs are associated with different ETS gene expression patterns. The presence of distinct prostate cancer subgroups with different biological features may have important clinical implications and suggests that assessment of ETS expression levels might be useful to distinguish tumors with different clinical outcome.

2010-06-09 | E-GEOD-14206 | biostudies-arrayexpress

Analysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers

2010-05-25 | GSE14206 | GEO